**INTRODUCTION:** The standard of care for critical-sized bony defects is autologous bone tissue transfer. However, its limitations (e.g., morbidity, secondary procedures, cost) have driven progress in alternatives such as tissue engineering-based treatments. We explored the bone regenerative capacity of customized, 3D printed bioactive ceramic (3DBC) scaffolds with dipyridamole (DIPY), an adenosine A2A receptor (A~2A~R) indirect agonist known to enhance bone formation, at the ramus of the rabbit mandible.

**METHODS:** Critical-sized bony defects (10mm height, 10mm length, full thickness) were created at the inferior aspect of the right mandibular rami of rabbits, adjacent to the angular process (n=15). Each defect was replaced by a custom-to-defect, 3DBC printed porous scaffold composed of β-tricalcium phosphate. Scaffolds were either uncoated (control), collagen-coated (COLL), or collagen coated and immersed in 100μM dipyridamole (DIPY). At t=8 weeks, animals were euthanized and the rami retrieved. Bone growth was assessed exclusively within scaffold pores, and evaluated by microCT/advanced reconstruction computer software. MicroCT quantification was calculated in segments as a function of distance from proximal to distal scaffold insertion. Bone morphology was assessed by histology. One-way ANOVA analysis was performed to compare group means, and 95% confidence intervals (CI) were included.

**RESULTS:** Qualitative analysis did not show an inflammatory response. On 3D analysis, the control and COLL groups (12.3 ± 8.3% and 6.9 ± 8.3% bone occupancy of free space, respectively) had less bone growth, while the most bone growth was in the DIPY group (26.9 ± 10.7%), a statistically significant difference (p\<0.03 DIPY vs. control and p\<0.01 DIPY vs. COLL). Evaluation of scaffold presence resulted in a significantly higher presence of material for the COLL group relative to the DIPY group (p\<0.015), whereas the control group presented intermediate values (non-significant relative to both COLL and DIPY). A general linear mixed model was performed for bone growth as a function of distance from the most proximal (deepest) aspect scaffold insertion site to the most superficial (distal at the mandibular border) aspect, for which DIPY-treated scaffolds demonstrated the most bone growth at the thinnest region of ramus bone at the proximal defect. Highly cellular and vascularized intramembranous-like bone healing was observed in all groups.

**CONCLUSION:** COL-DIPY significantly increased the 3DBC scaffold's ability to regenerate bone. Irrespective of treatment group, all scaffolds demonstrated bone regeneration with predominant focal growth at bone-scaffold interfaces.
